Genentech Announces FDA Approval of Xofluza for the Prevention of Influenza Following Contact With an Infected Person

South San Francisco, CA -- November 23, 2020 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news